Healthequity (HQY) Return on Sales (2016 - 2026)
Healthequity (HQY) has 13 years of Return on Sales data on record, last reported at 0.16% in Q4 2025.
- For Q4 2025, Return on Sales rose 14.0% year-over-year to 0.16%; the TTM value through Oct 2025 reached 0.15%, up 6.0%, while the annual FY2025 figure was 0.08%, 2.0% up from the prior year.
- Return on Sales reached 0.16% in Q4 2025 per HQY's latest filing, down from 0.18% in the prior quarter.
- Across five years, Return on Sales topped out at 0.18% in Q3 2025 and bottomed at 0.16% in Q1 2022.
- Average Return on Sales over 5 years is 0.04%, with a median of 0.02% recorded in 2021.
- Peak YoY movement for Return on Sales: decreased -19bps in 2022, then grew 16bps in 2023.
- A 5-year view of Return on Sales shows it stood at 0.03% in 2021, then skyrocketed by 73bps to 0.01% in 2022, then soared by 875bps to 0.06% in 2023, then crashed by -68bps to 0.02% in 2024, then skyrocketed by 746bps to 0.16% in 2025.
- Per Business Quant database, its latest 3 readings for Return on Sales were 0.16% in Q4 2025, 0.18% in Q3 2025, and 0.16% in Q2 2025.